Synergistic Effect of Epigenetic Inhibitors Decitabine and Suberoylanilide Hydroxamic Acid on Colorectal Cancer In vitro
Background: Colorectal Cancer (CRC) is a common cause of oncological deaths worldwide. Alterations of the epigenetic landscape constitute a well-documented hallmark of CRC phenotype. The accumulation of aberrant DNA methylation and histone acetylation plays a major role in altering gene activity and...
Saved in:
| Main Author: | Najem, Sonia A. (author) |
|---|---|
| Other Authors: | Khawaja, Ghada (author), Hodroj, Mohammad Hassan (author), Rizk, Sandra (author) |
| Format: | article |
| Published: |
2019
|
| Online Access: | http://hdl.handle.net/10725/11599 https://doi.org/10.2174/1874467212666190313154531 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://www.fasebj.org/doi/abs/10.1096/fasebj.2019.33.1_supplement.647.38 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adjuvant Epigenetic Therapy of Decitabine and Suberoylanilide Hydroxamic Acid Exerts Anti-Neoplastic Effects in Acute Myeloid Leukemia Cells
by: Abou Najem, Sonia
Published: (2019) -
Anti-neoplastic Effect of Adjuvant Epigenetic Therapy of Decitabine and Suberoylanilide Hydroxamic Acid on U937 Acute Myeloid Leukemia Cell Line
by: Babikian, Patil
Published: (2020) -
Hydroxamic acid-based histone deacetylase (HDAC) inhibitors can mediate neuroprotection independent of HDAC inhibition
by: Sleiman, Sama F.
Published: (2014) -
Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor—An Opportunity for Cancer Treatment
by: Mohammad A. I. Al-Hatamleh (11564929)
Published: (2019) -
Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy
by: Nassiba Taib (14557385)
Published: (2023)